Anika Therapeutics (AKP) Financial Statements

0 Followers

Anika Therapeutics Financial Overview

Anika Therapeutics's market cap is currently CHF229.61M. The company's EPS TTM is CHF-0.2695; its P/E ratio is -79.96; Anika Therapeutics is scheduled to report earnings on July 29, 2026, and the estimated EPS forecast is CHF0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 112.82M	$ 119.91M	$ 120.79M	$ 113.83M	$ 147.79M
Gross Profit	$ 63.81M	$ 76.00M	$ 82.53M	$ 73.22M	$ 82.94M
Operating Income	$ -11.05M	$ -5.10M	$ 844.00K	$ 3.67M	$ 2.62M
EBITDA	$ -3.58M	$ 5.36M	$ 17.37M	$ 18.81M	$ -4.16M
Net Income	$ -10.88M	$ -56.38M	$ -82.67M	$ -14.86M	$ 4.13M
Balance Sheet
Cash & Short-Term Investments	$ 57.48M	$ 55.63M	$ 68.74M	$ 86.33M	$ 94.39M
Total Assets	$ 190.27M	$ 202.74M	$ 270.63M	$ 349.13M	$ 347.54M
Total Debt	$ 26.25M	$ 25.93M	$ 27.74M	$ 30.89M	$ 20.95M
Net Debt	$ -31.23M	$ -29.70M	$ -41.00M	$ -55.44M	$ -73.43M
Total Liabilities	$ 46.80M	$ 48.75M	$ 58.37M	$ 63.56M	$ 60.45M
Stockholders' Equity	$ 143.47M	$ 153.99M	$ 212.26M	$ 285.56M	$ 287.08M
Cash Flow
Free Cash Flow	$ 4.36M	$ -2.33M	$ -7.21M	$ -3.08M	$ 3.25M
Operating Cash Flow	$ 11.19M	$ 5.40M	$ -1.79M	$ 4.41M	$ 8.40M
Investing Cash Flow	$ -401.00K	$ -8.33M	$ -5.43M	$ -7.49M	$ -3.12M
Financing Cash Flow	$ -10.55M	$ -12.73M	$ -6.32M	$ -4.85M	$ -6.78M

Currency in USD

Anika Therapeutics Earnings and Revenue History

Income Statement >

Anika Therapeutics Debt to Assets

Balance Sheet >

Anika Therapeutics Cash Flow

Cash Flow >

Anika Therapeutics Forecast EPS vs Actual EPS

Earnings >